BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33099529)

  • 21. [Investigation and analysis for current situation and pathogenesis relevant to pulmonary hypertension].
    Lei S; Tang D; Xu N; Wu S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):641-646. PubMed ID: 28690220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current trends in the management of pulmonary hypertension associated with respiratory disease in institutions approved by the Japanese Respiratory Society.
    Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Miyaji K; Takamura K; Hayashi S; Hanaoka M; Tatsumi K;
    Respir Investig; 2014 May; 52(3):167-72. PubMed ID: 24853016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.
    Amsallem M; Boulate D; Kooreman Z; Zamanian RT; Fadel G; Schnittger I; Fadel E; McConnell MV; Dhillon G; Mercier O; Haddad F
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):825-835. PubMed ID: 28120156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary hypertension in connective tissue disease].
    Schwarz EI; Ulrich S
    Z Rheumatol; 2018 Apr; 77(3):219-230. PubMed ID: 29594374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Pulmonary Hypertension Due to Chronic Lung Disease.
    Sugarman J; Weatherald J
    Methodist Debakey Cardiovasc J; 2021; 17(2):124-133. PubMed ID: 34326932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Our current understanding of and approach to the management of lung cancer with pulmonary hypertension.
    Dauriat G; LePavec J; Pradere P; Savale L; Fabre D; Fadel E
    Expert Rev Respir Med; 2021 Mar; 15(3):373-384. PubMed ID: 33107356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why there is a need to discuss pulmonary hypertension other than pulmonary arterial hypertension?
    Papathanasiou A; Nakos G
    World J Crit Care Med; 2015 Nov; 4(4):274-7. PubMed ID: 26557477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary hypertension in interstitial lung disease.
    Behr J; Ryu JH
    Eur Respir J; 2008 Jun; 31(6):1357-67. PubMed ID: 18515559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    Duarte AG; Lin YL; Sharma G
    J Heart Lung Transplant; 2017 Feb; 36(2):220-226. PubMed ID: 27595194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.
    Shlobin OA; Brown AW; Nathan SD
    Chest; 2017 Jan; 151(1):204-214. PubMed ID: 27554299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.
    Assad TR; Hemnes AR; Larkin EK; Glazer AM; Xu M; Wells QS; Farber-Eger EH; Sheng Q; Shyr Y; Harrell FE; Newman JH; Brittain EL
    J Am Coll Cardiol; 2016 Dec; 68(23):2525-2536. PubMed ID: 27931609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].
    Hachulla E; Launay D; Le Pavec J; Mouthon L; Guillevin L; de Groote P
    Presse Med; 2011 Apr; 40 Suppl 1():1S46-53. PubMed ID: 21536180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].
    Liu XQ; Yan H; Qiu JX; Zhang CY; Qi JG; Zhang X; Xiao HJ; Yang YL; Chen YH; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):768-777. PubMed ID: 29045954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pulmonary hypertension in chronic respiratory and cardiac diseases].
    Cordier JF
    Rev Prat; 2008 Nov; 58(18):2019-23. PubMed ID: 19143273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Diagnostic Challenge of Group 2 Pulmonary Hypertension.
    Naeije R; D'Alto M
    Prog Cardiovasc Dis; 2016; 59(1):22-9. PubMed ID: 27195751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary arterial hypertension and women.
    De Marco T
    Cardiol Rev; 2006; 14(6):312-8. PubMed ID: 17053380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
    Pitsiou G; Papakosta D; Bouros D
    Respiration; 2011; 82(3):294-304. PubMed ID: 21677422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pulmonary hypertension associated with lung disease].
    Halank M; Zeder KE; Sommer N; Ulrich S; Held M; Köhler T; Foris V; Heberling M; Neurohr C; Ronczka J; Holt S; Skowasch D; Kneidinger N; Behr J
    Pneumologie; 2023 Nov; 77(11):916-925. PubMed ID: 37963481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Gologanu D; Stanescu C; Bogdan MA
    Rom J Intern Med; 2012; 50(4):259-68. PubMed ID: 23610973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.